Skip to main content
. 2023 Nov 17;17(11):e13216. doi: 10.1111/irv.13216

FIGURE 2.

FIGURE 2

Description of symptoms suggestive of COVID‐19 in study participants who tested positive for SARS‐CoV‐2 antibodies by age group in Ouagadougou and Bobo‐Dioulasso (Burkina Faso, March 2021). (A) Prevalence of symptoms in participants who tested positive for anti‐SARS‐CoV‐2 antibodies according to age. (B) Prevalence of symptoms in participants who tested positive for anti‐SARS‐CoV‐2 antibodies according to age and sex in participants aged over 18 years old. (C) Description of symptoms suggestive of COVID‐19 in participants aged over 18 years old, (D) Prevalence of symptoms in participants who tested positive for anti‐SARS‐CoV‐2 antibodies according to age and sex in participants aged 10–18 years old. (E) Description of symptoms suggestive of COVID‐19 in participants aged 10–18 years old.